Abstract:BACKGROUND:Neuropathic pain is still a challenge for clinical treatment as a result of the comprehensive pathogenesis. Although emerging evidence demonstrates the pivotal role of glial cells in regulating neuropathic pain, the role of Schwann cells and their underlying mechanisms still need to be uncovered. Pannexin 1 (Panx 1), an important membrane channel for the release of ATP and inflammatory cytokines, as well as its activation in central glial cells, contributes to pain development. Here, we hypothesized that Schwann cell Panx 1 participates in the regulation of neuroinflammation and contributes to neuropathic pain.METHODS:A mouse model of chronic constriction injury (CCI) in CD1 adult mice or P0-Cre transgenic mice, and in vitro cultured Schwann cells were used. Intrasciatic injection with Panx 1 blockers or the desired virus was used to knock down the expression of Panx 1. Mechanical and thermal sensitivity was assessed using Von Frey and a hot plate assay. The expression of Panx 1 was measured using qPCR, western blotting, and immunofluorescence. The production of cytokines was monitored through qPCR and enzyme-linked immunosorbent assay (ELISA). Panx1 channel activity was detected by ethidium bromide (EB) uptake.RESULTS:CCI induced persistent neuroinflammatory responses and upregulation of Panx 1 in Schwann cells. Intrasciatic injection of Panx 1 blockers, carbenoxolone (CBX), probenecid, and Panx 1 mimetic peptide (10Panx) effectively reduced mechanical and heat hyperalgesia. Probenecid treatment of CCI-induced mice significantly reduced Panx 1 expression in Schwann cells, but not in dorsal root ganglion (DRG). In addition, Panx 1 knockdown in Schwann cells with Panx 1 shRNA-AAV in P0-Cre mice significantly reduced CCI-induced neuropathic pain. To determine whether Schwann cell Panx 1 participates in the regulation of neuroinflammation and contributes to neuropathic pain, we evaluated its effect in LPS-treated Schwann cells. We found that inhibition of Panx 1 via CBX and Panx 1-siRNA effectively attenuated the production of selective cytokines, as well as its mechanism of action being dependent on both Panx 1 channel activity and its expression.CONCLUSION:In this study, we found that CCI-related neuroinflammation correlates with Panx 1 activation in Schwann cells, indicating that inhibition of Panx 1 channels in Schwann cells reduces neuropathic pain through the suppression of neuroinflammatory responses.

Cholecystokinin type B receptor-mediated inhibition of A-type K + channels enhances sensory neuronal excitability through the phosphatidylinositol 3-kinase and c-Src-dependent JNK pathway

Pi3k Contributed To Modulation Of Spinal Nociceptive Information Related To Ephrinbs/Ephbs

CCK-8 enhances acid-sensing ion channel currents in rat primary sensory neurons

Vagal Afferent-Dependent Cholecystokinin Modulation of Visceral Pain Requires Central Amygdala Nmda-Nr2b Receptors in Rats

Cholecystokinin octapeptide increases spontaneous glutamatergic synaptic transmission to neurons of the nucleus tractus solitarius centralis

Signal Transduction Pathways Mediating CCK-8S-induced Gastric Antral Smooth Muscle Contraction.

[The Role of Protein Kinase C-mediated Phosphorylation of Type III Inositol 1, 4, 5-Triphosphate Receptor in Cholecystokinin Octapeptide Induced Calcium Mobilization in Gastric Antral Smooth Muscle Cells].

Interleukin 33-mediated inhibition of A-type K + channels induces sensory neuronal hyperexcitability and nociceptive behaviors in mice

Inhibition of Schwann Cell Pannexin 1 Attenuates Neuropathic Pain Through the Suppression of Inflammatory Responses

Interleukin 33-mediated inhibition of A-type K<SUP>+</SUP> channels induces sensory neuronal hyperexcitability and nociceptive behaviors in mice

Neuromedin B Receptor Stimulation Of Cav3.2 T-Type Ca2+ Channels In Primary Sensory Neurons Mediates Peripheral Pain Hypersensitivity

Neuromedin B receptor stimulation of Cav3.2 T-type Ca 2+ channels in primary sensory neurons mediates peripheral pain hypersensitivity

Modulation of A-type K+ Channels by the Short-Chain Cobrotoxin Through the Protein Kinase C-delta Isoform Decreases Membrane Excitability in Dorsal Root Ganglion Neurons

Adiponectin receptor 1-mediated stimulation of Cav3.2 channels in trigeminal ganglion neurons induces nociceptive behaviors in mice

PKC–NF-κB Are Involved in CCL2-induced Nav1.8 Expression and Channel Function in Dorsal Root Ganglion Neurons

Cholecystokinin enhances visceral pain-related affective memory via vagal afferent pathway in rats

Cholecystokinin Octapeptide Reverses the Inhibitory Effect Induced by Electroacupuncture on C-Fiber Evoked Discharges

Melanocortin type 4 receptor–mediated inhibition of A-type K+ current enhances sensory neuronal excitability and mechanical pain sensitivity in rats

Serotonin Type-1D Receptor Stimulation of A-type K(+) Channel Decreases Membrane Excitability Through the Protein Kinase A- and B-Raf-dependent P38 MAPK Pathways in Mouse Trigeminal Ganglion Neurons.

Insulin-like Growth Factor-1 Receptor-Mediated Inhibition of A-type K(+) Current Induces Sensory Neuronal Hyperexcitability Through the Phosphatidylinositol 3-Kinase and Extracellular Signal-Regulated Kinase 1/2 Pathways, Independently of Akt.

CC Chemokine Ligand 2 (CCL2) Enhances TTX-sensitive Sodium Channel Activity of Primary Afferent Neurons in the Complete Freud Adjuvant-Induced Inflammatory Pain Model